文献速递产科母胎医学

胎盘组织学用于复发性自发性早产的目标性风险评估

Placental histology for targeted risk assessment of recurrent spontaneous preterm birth.
PubMed 文献 · Am J Obstet Gynecol · 2023-09-24

本回顾性队列研究纳入352例单胎妊娠且有索引自发性早产及后续分娩的孕妇,分析4种胎盘组织学类型与复发性早产的关系,并评估其与17-羟孕酮己酸酯(17-OHPC)反应的关系。结果显示无组织学类型与复发性早产独立相关;低级别急性炎症与17-OHPC反应降低显著相关,低级别母体血管灌注不良在索引分娩<36周者中与17-OHPC反应增加4倍以上相关。

要点

  • 急性炎症是自发性早产中最常见的组织学类型(44.1%),但超过半数自发性早产与急性炎症无关。
  • 低级别急性炎症与17-OHPC反应降低显著相关。
  • 索引分娩<36周者中,低级别母体血管灌注不良与17-OHPC反应增加4倍以上相关。

核心结论

  • 急性炎症在自发性早产中常见,但超过半数自发性早产与急性炎症无关。
  • 低级别急性炎症与对17-羟孕酮己酸酯补充的反应显著降低相关。
  • 在索引分娩<36周者中,低级别母体血管灌注不良与17-羟孕酮己酸酯反应增加4倍的可能性相关。
  • 需要进一步研究以确定胎盘病理检查是否可用于指导后续妊娠的治疗以预防复发性早产。

研究设计与样本

  • 本研究为单中心回顾性队列研究,纳入2009年至2019年间在同一医院系统内有过索引自发性早产并随后分娩的单胎妊娠妇女。
  • 纳入标准为索引自发性早产有胎盘病理结果可用。
  • 采用逻辑回归分析4种组织学类型(急性炎症、母体血管灌注不良、胎儿血管灌注不良、慢性炎症)与复发性早产的独立关联。
  • 次要终点中,17-羟孕酮己酸酯反应定义为妊娠延长时间超过索引妊娠分娩孕龄3周以上;排除索引妊娠后3周内分娩但孕龄≥39周者。
  • 敏感性分析仅纳入索引分娩<36周者,并排除后续妊娠中医学指征早产者;另嵌套病例对照免疫组化研究纳入20例后续足月分娩和20例后续自发性早产患者。

主要发现

  • 共纳入352例患者;急性炎症是最常见的组织学类型(44.1%),其次为慢性炎症(40.9%)和母体血管灌注不良(31.3%)。
  • 无组织学类型与复发性早产独立相关。
  • 155例患者在第二次妊娠中接受了17-羟孕酮己酸酯治疗;低级别急性炎症与17-羟孕酮己酸酯反应降低显著相关。
  • 在索引妊娠<36周分娩者中,排除后续医源性早产后,低级别母体血管灌注不良与17-羟孕酮己酸酯反应增加4倍以上显著相关。
  • 蜕膜孕激素受体染色与复发性早产无关。

临床怎么用

  • 作者认为,需要进一步研究以确定胎盘病理检查是否可用于指导后续妊娠的治疗以预防复发性早产。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spontaneous preterm birth significantly increases the risk for a recurrent preterm birth. Only a few identifiable clinical risk factors can be referenced in counseling for recurrent preterm birth. Furthermore, treatment using progesterone supplementation has not consistently prevented preterm birth among high-risk patients, but it may be effective in a subset of those patients. Placental pathology from a previous pregnancy may be used to predict which patients will experience a recurrent preterm birth or to identify a subset of patients more likely to respond to treatment with antenatal progesterone. OBJECTIVE: This study aimed to determine if histologic patterns are associated with recurrent preterm birth among patients with an index spontaneous preterm birth. A secondary objective was to determine if placental histologic types and/or progesterone receptor density in the decidua are associated with the response to progesterone supplementation with intramuscular 17-hydroxyprogesterone caproate. STUDY DESIGN: This was a retrospective cohort study at a single institution of women with singleton pregnancies with an index spontaneous preterm birth and a subsequent birth within the same hospital system between 2009 and 2019. Patients were included if placental pathology was available for the index spontaneous preterm birth. A logistic regression was used to determine if there were independent associations between 4 histologic types (acute inflammation, maternal vascular malperfusion, fetal vascular malperfusion, chronic inflammation) and recurrent preterm birth. For the secondary endpoint, 17-hydroxyprogesterone caproate response was defined as prolonging gestation by >3 weeks beyond the gestational age at delivery in the index pregnancy. Patients who delivered <3 weeks beyond the gestational age in the index pregnancy but at ≥39 weeks' gestation were excluded. A logistic regression was used to assess the independent association between placental histology and 17-hydroxyprogesterone caproate response. Sensitivity analyses were completed using only patients with an index birth <36 weeks' gestation, and then excluding those with medically indicated preterm birth in a subsequent pregnancy. A nested case-control immunohistochemical study was done among 20 patients with a subsequent term birth and 20 patients with a subsequent spontaneous preterm birth. The percentage of cells in the maternal decidua positive for progesterone receptors was correlated with the subsequent pregnancy outcome. RESULTS: A total of 352 patients were included. Acute inflammation was the most common histologic type seen among patients with spontaneous preterm birth (44.1%), followed by chronic inflammation (40.9%) and maternal vascular malperfusion (31.3%). No histologic type was independently associated with recurrent preterm birth. A total of 155 patients received 17-hydroxyprogesterone caproate in a second pregnancy. Low-grade acute inflammation was significantly associated with a decreased likelihood of 17-hydroxyprogesterone caproate response. Low-grade maternal vascular malperfusion among those with an index pregnancy delivered at <36 weeks' gestation was significantly associated with a more than 4 times increased likelihood of 17-hydroxyprogesterone caproate response when excluding those with a subsequent iatrogenic preterm birth. Progesterone receptor staining was not associated with recurrent preterm birth. CONCLUSION: Although acute inflammation was prevalent among spontaneous preterm births, more than half of the spontaneous preterm births were not associated with acute inflammation. Low-grade acute inflammation was associated with a significantly decreased response to 17-hydroxyprogesterone caproate supplementation. Low-grade maternal vascular malperfusion was associated with a 4-fold increased likelihood of 17-hydroxyprogesterone caproate response among those with index deliveries <36 weeks' gestation. Further work is needed to determine if placental pathologic examination can be used to target treatment in subsequent pregnancies to prevent recurrent preterm birth.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Suresh S, Freedman A, Adams M, et al. Placental histology for targeted risk assessment of recurrent spontaneous preterm birth. Am J Obstet Gynecol. 2023. PMID: 37751829. doi:10.1016/j.ajog.2023.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。